BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26402946)

  • 1. [Effect of probiotic product containing bifidobacteria and biogel from brown algae on the intestinal microflora and parameters of innate immunity in mice with experimental drug dysbacteriosis].
    Kuznetsova TA; Makarenkova ID; Koneva EL; Aminina NM; Yakush EV
    Vopr Pitan; 2015; 84(1):73-9. PubMed ID: 26402946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [EFFECT OF POLYCOMPONENT PROBIOTICS ON THE COMPOSITION OF COLON MICROBIOCENOSIS DURING EXPERIMENTAL DYSBIOSIS].
    Ageichenko AV; Kalutsky PV; Medvedeva OA; Korolev VA
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (4):80-4. PubMed ID: 26470424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.
    Makizaki Y; Maeda A; Oikawa Y; Tamura S; Tanaka Y; Nakajima S; Ohno H; Yamamura H
    Microbiol Immunol; 2019 Dec; 63(12):481-486. PubMed ID: 31544979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corrective action of bacillary probiotic on the immune system of animals in experimential dysbacteriosis].
    Didenko GV; Safronova LA; Shpak EG; Avdeeva LV; Potebnia GP
    Lik Sprava; 2013 Dec; (8):108-16. PubMed ID: 25726686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism.
    Din AU; Hassan A; Zhu Y; Zhang K; Wang Y; Li T; Wang Y; Wang G
    J Nutr Biochem; 2020 May; 79():108353. PubMed ID: 32145470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ceftriaxone-induced intestinal dysbacteriosis on dendritic cells of small intestine in mice.
    Li M; Li W; Wen S; Liu Y; Tang L
    Microbiol Immunol; 2013 Aug; 57(8):561-8. PubMed ID: 23650903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of monostrain and multistrain probiotics on immunity, intestinal ultrastructure and microbiota in experimental dysbiosis.
    Ermolenko E; Rybalchenko O; Borshev Y; Tarasova E; Kramskaya T; Leontieva G; Kotyleva M; Orlova O; Abdurasulova I; Suvorov A
    Benef Microbes; 2018 Dec; 9(6):937-949. PubMed ID: 30099893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
    Drozdov VN; Shikh EV; Astapovskii AA; Khalaidzheva KN; Solovieva SA; Dorogun OB
    Vopr Pitan; 2023; 92(4):92-103. PubMed ID: 37801459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of selenium enriched-Bifidobacterium longum DD98, and its repairing effects on antibiotic-induced intestinal dysbacteriosis in mice.
    Zhu H; Zhou Y; Qi Y; Ji R; Zhang J; Qian Z; Wu C; Tan J; Shao L; Chen D
    Food Funct; 2019 Aug; 10(8):4975-4984. PubMed ID: 31343650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a probiotic mixture on intestinal microflora, morphology, and barrier integrity of broilers subjected to heat stress.
    Song J; Xiao K; Ke YL; Jiao LF; Hu CH; Diao QY; Shi B; Zou XT
    Poult Sci; 2014 Mar; 93(3):581-8. PubMed ID: 24604851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of probiotic fermented milk product on colon microbiota, hematological parameters and cell immunity in rats].
    Kuznetsova GG; Trushina ÉN; Muatafina OK; Cherkashin AV; Batishcheva SIu; Semenikhina VF; Sheveleva SA
    Vopr Pitan; 2012; 81(3):18-23. PubMed ID: 22888666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of microbial community structure in turbot (Scophthalmus maximus) larval intestine to the regulation of probiotic introduced through live feed.
    Jiang Y; Wang Y; Zhang Z; Liao M; Li B; Rong X; Chen G
    PLoS One; 2019; 14(5):e0216590. PubMed ID: 31067264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immune response, microbiota, and blood markers after probiotic bacteria administration in obese mice induced by a high-fat diet.
    Núñez IN; Galdeano CM; de LeBlanc Ade M; Perdigón G
    Nutrition; 2014; 30(11-12):1423-32. PubMed ID: 25280423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.
    Piano MD; Carmagnola S; Ballarè M; Balzarini M; Montino F; Pagliarulo M; Anderloni A; Orsello M; Tari R; Sforza F; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S85-92. PubMed ID: 22955366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tactics for the correction of intestinal microbiocenotic disorders in the combination therapy of patients with chronic liver diseases].
    Chikhacheva EA; Seliverstov PV; Sitkin SI; Dobritsa VP; Radchenko VG
    Ter Arkh; 2014; 86(4):52-7. PubMed ID: 24864468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of intestinal microflora in chemotherapeutic dysbacteriosis using bifidobacterial and lactobacterial autologous strains].
    Korshunov VM; Sinitsyna NA; Ginodman GA; Pinegin BV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):20-5. PubMed ID: 4072493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probiotics on the basis of Bacillus subtilis and Bifidobacterium longum on the biochemical parameters of the animal organism.
    Kvan OV; Gavrish IA; Lebedev SV; Korotkova AM; Miroshnikova EP; Serdaeva VA; Bykov AV; Davydova NO
    Environ Sci Pollut Res Int; 2018 Jan; 25(3):2175-2183. PubMed ID: 29116533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
    Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
    Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.